Boston Scientific
731 hedge funds and large institutions have $45.1B invested in Boston Scientific in 2018 Q4 according to their latest regulatory filings, with 107 funds opening new positions, 257 increasing their positions, 245 reducing their positions, and 69 closing their positions.
105% more call options, than puts
Call options by funds: $176M | Put options by funds: $85.6M
55% more first-time investments, than exits
New positions opened: 107 | Existing positions closed: 69
11% more funds holding in top 10
Funds holding in top 10: 18 → 20 (+2)
5% more funds holding
Funds holding: 699 → 731 (+32)
5% more repeat investments, than reductions
Existing positions increased: 257 | Existing positions reduced: 245
0.24% less ownership
Funds ownership: 92.42% → 92.18% (-0.24%)
8% less capital invested
Capital invested by funds: $49.2B → $45.1B (-$4.12B)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
+$366M |
| 2 |
FAM
Fred Alger Management
New York
|
+$188M |
| 3 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$179M |
| 4 |
BlackRock
New York
|
+$152M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
+$133M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$462M |
| 2 |
Norges Bank
Oslo,
Norway
|
-$168M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$152M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$115M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
-$109M |
BSX Hedge Fund Activity: Q4 2018 in Review
731 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q4 2018, worth a combined $45.1B — down 8.4% from $49.2B a quarter earlier.
Buyers outnumbered sellers: 107 funds opened new BSX positions and 69 closed out — a net gain of 38 holders — while 257 added to existing stakes and 245 trimmed.
The largest buyer was Capital World Investors, adding an estimated $366M. The largest seller was Fidelity Investments, cutting an estimated $462M.
- 731 institutional investors held Boston Scientific (BSX) as of Q4 2018, up from 699 in Q3 2018.
- Funds reported $45.1B of Boston Scientific stock for Q4 2018, down 8.4% quarter-over-quarter.
- 107 funds opened new Boston Scientific positions in Q4 2018 and 69 closed out, a net change of +38 holders.
- The largest Boston Scientific buyer in Q4 2018 was Capital World Investors, an estimated $366M added.
- The largest Boston Scientific seller in Q4 2018 was Fidelity Investments, an estimated $462M sold.
Based on aggregated 13F filings for Q4 2018.